molybdenum has been researched along with Colitis Gravis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Jiang, H; Jiang, Z; Li, D; Li, M; Lin, Y; Su, Y; Xiao, Y; Yan, Z; Yang, F; Yang, M | 1 |
1 other study(ies) available for molybdenum and Colitis Gravis
| Article | Year |
|---|---|
pH-sensitive molybdenum (Mo)-based polyoxometalate nanoclusters have therapeutic efficacy in inflammatory bowel disease by counteracting ferroptosis.
Topics: Animals; Colitis, Ulcerative; Dextran Sulfate; Disease Models, Animal; Ferroptosis; Hydrogen-Ion Concentration; Mice; Molybdenum; Reactive Oxygen Species | 2023 |